• Astepro® (azelastine hydrochloride) Nasal Spray 0.15%

    Important Risk Information:
    •Avoid engaging in hazardous occupations requiring complete mental alertness when taking ASTEPRO Nasal Spray 0.15%.
    •Avoid concurrent use of alcohol or other central nervous system depressants with ASTEPRO Nasal Spray 0.15%.
    •In clinical studies, the most common reported adverse reactions, when dosed at 2 sprays per nostril once or twice daily, respectively, included bitter taste (4%,6%), nasal discomfort (4%,3%), epistaxis (2%,1%) and sneezing (1%,2%).
    •Please see full Prescribing Information.



  • DYMISTATM (azelastine hydrochloride and fluticasone propionate) Nasal Spray 137 mcg / 50 mcg per Spray




  • Elestrin® (estradiol gel)
    Click for Important Safety Information



  • Gesticare DHA®
    (Prenatal Multi-vitamin/Mineral Tablets
    with DHA and Choline)

    WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.




  • Muse® (alprostadil) Urethral Suppository



  • Natelle One®
    (Rx Prenatal Vitamin & Plant-Based DHA.
    Now with 28 mg Iron)

    WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.



  • PreferaOB® Family of Products


    WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Featured Products
Astepro 0.15Dymista® Nasal Spray
EdluarElestrin
GesticareMuse
Natelle OnePrefera OB 

Meda Pharmaceuticals Inc. is the U.S. subsidiary of Meda AB.

The Meda Pharmaceutical product portfolio is focused primarily on respiratory, allergy, central nervous system, gastroenterology, musculoskeletal, rheumatology, erectile dysfunction, and women's health products.

Latest News
October 15, 2012:
Acquisition of Women's Health products completed »

September 6, 2012:
Meda acquires Women's Health products in the U.S. »

Independent Education Grants
Meda Pharmaceuticals Inc. supports bona fide educational programs through the provision of educational grants.